Carnosine metabolism in diabetes is altered by reactive metabolites

Amino Acids

Volumn 47, Issue 11, 2015, Pages 2367-2376

  Peters, Verena ^a   Lanthaler, Barbara ^b   Amberger, Albert ^b   Fleming, Thomas ^a   Forsberg, Elisabete ^c   Hecker, Markus ^a   Wagner, Andreas H ^a   Yue, Wyatt W ^d   Hoffmann, Georg F ^a   Nawroth, Peter ^a   Zschocke, Johannes ^b   Schmitt, Claus P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anserine; Carnosinase; Carnosine; Diabetic nephropathy; N carbonylation; S nitrosylation

Indexed keywords

ANSERINE; CARNOSINASE 1; CARNOSINE; CYSTEINE; DIPEPTIDE; FENTON REAGENT; GLUCOSE; GLUTATHIONE; HISTIDINE DIPEPTIDE; INSULIN; LEPTIN; MESSENGER RNA; METALLOPROTEINASE; METHYLGLYOXAL; NITRATE; NITRIC OXIDE; NITROGEN DIOXIDE; OXIDIZING AGENT; REACTIVE CARBONYL METABOLITE; REACTIVE OXYGEN METABOLITE; REAGENT; UNCLASSIFIED DRUG; AMINOACYL-HISTIDINE DIPEPTIDASE; DIPEPTIDASE; FENTON'S REAGENT; HYDROGEN PEROXIDE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DB/DB MOUSE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; EX VIVO STUDY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; MOUSE; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN METABOLISM; PROTEIN PROCESSING; WILD TYPE MOUSE; ANIMAL; GENETICS; HUMAN; METABOLISM; MUTANT MOUSE STRAIN; MUTATION; PATHOLOGY;

ANIMALS; CARNOSINE; DIABETES MELLITUS; DIPEPTIDASES; HUMANS; HYDROGEN PEROXIDE; IRON; MICE; MICE, MUTANT STRAINS; MUTATION; NITRIC OXIDE; PYRUVALDEHYDE;

EID: 84945496049     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-015-2024-z     Document Type: Article

References (57)

1. Aldini G, Facino RM, Beretta G, Carini M (2005) Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. BioFactors (Oxford, England) 24:77-87
2. Alhamdani M, Al-Azzawie HF, Abbas FK (2007) Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides. Perit Dial Int 27:86-89
3. Ansurudeen I et al (2012) Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 43:127-134. doi: 10.1007/s00726-012-1269-z
4. Babizhayev MA, Lankin VZ, Savel'Yeva EL, Deyev AI, Yegorov YE (2013) Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants. Recent Pat Drug Deliv Formul 7:216-256
5. Barski OA et al (2013) Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 33:1162-1170. doi: 10.1161/atvbaha.112.300572
6. Baylis C (2012) Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 21:1-6. doi: 10.1097/MNH.0b013e32834d54ca
7. Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803-1845. doi: 10.1152/physrev.00039.2012
8. Budzen S, Rymaszewska J (2013) The biological role of carnosine and its possible applications in medicine. Adv Clin Exp Med Off Organ Wroc Med Univ 22:739-744
9. Chang CY et al (2010) Crystal structure and mutational analysis of aminoacylhistidine dipeptidase from Vibrio alginolyticus reveal a new architecture of M20 metallopeptidases. J Biol Chem 285:39500-39510. doi: 10.1074/jbc.M110.139683
10. Cheang WS et al (2011) Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice. Cardiovasc Res 92:267-275. doi: 10.1093/cvr/cvr233
11. Curtis JM, Hahn WS, Long EK, Burrill JS, Arriaga EA, Bernlohr DA (2012) Protein carbonylation and metabolic control systems. Trends Endocrinol Metab 23:399-406. doi: 10.1016/j.tem.2012.05.008
12. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A (2006) Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10:389-406 (pii:010.002.11)
13. Decker E, Livisay SA, Zhou S (2000) A re-evaluation of the antioxidant activity of purified carnosine. Biochemistry (Mosc) 65:766-770
14. Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ (2006) Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 55:1961-1969. doi: 10.2337/db05-1634
15. Drozak J, Veiga-da-Cunha M, Vertommen D, Stoobant V, Van Schaftingen E (2010) Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). J Biol Chem 2685:9346-9356
16. Drozak J, Chrobok L, Poleszak O, Jagielski AK, Derlacz R (2013) Molecular identification of carnosine N-methyltransferase as chicken histamine N-methyltransferase-like protein (hnmt-like). PLoS One 8:e64805. doi: 10.1371/journal.pone.0064805
17. Forrester M, Foster MW, Benhar M, Stamler JS (2009) Detection of protein S-nitrosylation with the biotin switch technique. Free Radic Biol Med 46:119-126
18. Forstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(829-837):837a-837d. doi: 10.1093/eurheartj/ehr304
19. Foster MW, Hess DT, Stamler JS (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med 15:391-404. doi: 10.1016/j.molmed.2009.06.007
20. Freedman BI, Bostrom M, Daeihagh P, Bowden DW (2007) Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2:1306-1316. doi: 10.2215/CJN.02560607
21. Gould N, Doulias PT, Tenopoulou M, Raju K, Ischiropoulos H (2013) Regulation of protein function and signaling by reversible cysteine S-nitrosylation. J Biol Chem. doi: 10.1074/jbc.R113.460261
22. Hartmanova T, Tambor V, Lenco J, Staab-Weijnitz CA, Maser E, Wsol V (2013) S-Nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity. Chem Biol Interact. doi: 10.1016/j.cbi.2012.12.011
23. Hipkiss AR (2011) Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. Mol Aspect Med 32:267-278
24. Holliday R, McFarland GA (1996) Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine. Br J Cancer 73:966-971
25. Hou W, Chen HJ, Lin YH (2003) Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification. J Agric Food Chem 51:1706-17093
26. Janssen B et al (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54:2320-2327 (pii: 54/8/2320)
27. Kohen R, Yamamoto Y, Cundy KC, Ames BN (1988) Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179
28. Lapolla A, Reitano R, Seraglia R, Sartore G, Ragazzi E, Traldi P (2005) Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress. Mol Nutr Food Res 49:685-690. doi: 10.1002/mnfr.200400093
29. Letzien U, Oppermann H, Meixensberger J, Gaunitz F (2014) The antineoplastic effect of carnosine is accompanied by induction of PDK4 and can be mimicked by l-histidine. Amino Acids 46:1009-1019. doi: 10.1007/s00726-014-1664-8
30. Maisonneuve E, Ducret A, Khoueiry P, Lignon S, Longhi S, Talla E, Dukan S (2009) Rules governing selective protein carbonylation. PLoS One 4:e7269. doi: 10.1371/journal.pone.0007269
31. Masha A, Dinatale S, Allasia S, Martina V (2011) Role of the decreased nitric oxide bioavailability in the vascular complications of diabetes mellitus. Curr Pharm Biotechnol 12:1354-1363 (pii:BSP/CPB/E-Pub/-00061-12-5)
32. Min J et al (2008) Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia. J Neurosci Res 86:2984-2991. doi: 10.1002/jnr.21744
33. Mong MC, Chao CY, Yin MC (2011) Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet. Eur J Pharmacol 653:82-88. doi: 10.1016/j.ejphar.2010.12.001
34. Mooyaart AL et al (2010) Association between CNDP1 genotype and diabetic nephropathy is sex specific. Diabetes 59:1555-1559. doi: 10.2337/db09-1377
35. Mozdan M, Szemraj J, Rysz J, Nowak D (2005) Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. Basic Clin Pharmacol Toxicol 96:352-360
36. Nakagawa K, Ueno A, Nishikawa Y (2006) Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro Yakugaku zasshi. J Pharm Soc Jpn 126:37-42
37. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R (2008) Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 153:6-20. doi: 10.1038/sj.bjp.0707395
38. Nystrom T (2005) Role of oxidative carbonylation in protein quality control and senescence. EMBO J 24:1311-1317. doi: 10.1038/sj.emboj.7600599
39. Orioli M, Aldini G, Benfatto MC, Facino RM, Carini M (2007) HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats. Anal Chem 79:9174-9184. doi: 10.1021/ac7016184
40. Peters V et al (2010) Relevance of allosteric conformations and homocarnosine concentration on carnosinase activity. Amino Acids 38:1607-1615. doi: 10.1007/s00726-009-0367-z
41. Peters V et al (2011) Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration. Clin Chim Acta 412:263-267. doi: 10.1016/j.cca.2010.10.016
42. Peters V, Schmitt CP, Zschocke J, Gross ML, Brismar K, Forsberg E (2012) Carnosine treatment largely prevents alterations of renal carnosine metabolism in diabetic mice. Amino Acids 42:2411-2416. doi: 10.1007/s00726-011-1046-4
43. Peters V et al (2014) Carnosine treatment in combination with ACE inhibition in diabetic rats. Regul Pept. doi: 10.1016/j.regpep.2014.09.005
44. Pfister F et al (2011) Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem 28:125-136. doi: 10.1159/000331721
45. Pollock JS, Pollock DM (2011) Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease. Contrib Nephrol 172:149-159. doi: 10.1159/000329054
46. Riedl E et al (2010) N-glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia. Diabetes 59:1984-1990. doi: 10.2337/db09-0868
47. Riedl E et al (2011) Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem 28:279-288. doi: 10.1159/000331740
48. Ruskovska T, Bernlohr DA (2013) Oxidative stress and protein carbonylation in adipose tissue - implications for insulin resistance and diabetes mellitus. J Proteomics. doi: 10.1016/j.jprot.2013.04.002
49. Sena CM, Pereira AM, Seica R (2013) Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta 1832:2216-2231. doi: 10.1016/j.bbadis.2013.08.006
50. Somineni HK, Boivin GP, Elased KM (2014) Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice. J Endocrinol 221:235-251. doi: 10.1530/joe-13-0532
51. Stegen S et al (2015) Muscle histidine-containing dipeptides are elevated by glucose intolerance in both rodents and men. PLoS One 10:e0121062. doi: 10.1371/journal.pone.0121062
52. Tanida M, Shen J, Kubomura D, Nagai K (2010) Effects of anserine on the renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Physiol Res 59:177-185
53. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D, Ganzhorn AJ, Guenet C, Heintzelmann B, Laucher V, Sauvage C, Smirnova T (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278:6251-6531
54. Velez S, Nair NG, Reddy VP (2008) Transition metal ion binding studies of carnosine and histidine: biologically relevant antioxidants Colloids and surfaces B. Biointerfaces 66:291-294. doi: 10.1016/j.colsurfb.2008.06.012
55. Vistoli G et al (2009) Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. ChemMedChem 4:967-975. doi: 10.1002/cmdc.200800433
56. Voziyan P, Brown KL, Chetyrkin S, Hudson B (2014) Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes. Clin Chem Lab Med CCLM FESCC 52:39-45. doi: 10.1515/cclm-2012-0818
57. Wagner AH et al (2011) Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signaling in human endothelial cells. Blood 118:3734-3742. doi: 10.1182/blood-2010-11-320259